Artificial intelligence (AI) software developer RapidAI has inked a partnership agreement with therapy products firm Penumbra to create new tools aimed at streamlining triage and decision-making in the diagnosis and treatment of pulmonary embolism (PE).
These modules will process CT scans and then deliver clear and easy-to-interpret images directly to the physician, according to Penumbra.
